SAN MATEO, Calif., July 21, 2011 (GLOBE NEWSWIRE) -- Epocrates, Inc. (Nasdaq:EPOC), a leading provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry, will release its 2011 second quarter financial results on Tuesday, August 9, 2011, after regular market trading hours.
The company also announced that pursuant to the terms of the lock-up agreements between its pre-IPO stockholders and the IPO underwriters, the term of the lock-up period set forth in these agreements has been automatically extended through and including August 26, 2011. Consequently, the first day that pre-IPO stockholders who are currently subject to a lock-up may trade shares of Epocrates' common stock is August 29, 2011.
The lock-up agreements restrict dispositions of company securities prior to a date which is 180 days after the effective date of the company's initial public offering, unless prior to the expiration of the 180-day restricted period, the company announces that it will release earnings results during the 16-day period following the last day of the initial 180 day lock-up period, in which case the lock-up period will be extended until the expiration of the 18-day period beginning on the date of the earnings release.
Epocrates will host a conference call and webcast at 5:00 p.m. Eastern Time on August 9, 2011. Epocrates' management will review its 2011 second quarter results and future outlook, followed by a question and answer session.
To participate in Epocrates' live conference call and webcast, please dial 877-398-9481 (if dialing from within the U.S.) or 760-298-5095 (if dialing from outside the U.S.) using conference code 76939225 or visit the Investor Relations section of Epocrates' website at http://investor.epocrates.com.
A replay of the conference call will be available approximately two hours after the completion of the conference call by dialing 800-642-1687 (if dialing from within the U.S.) or 706-645-9291 (if dialing from outside the U.S.) using conference code 76939225. The replay will be available for one week on the above number. A webcast replay will also be archived on Epocrates' website for approximately 12 months.
About Epocrates, Inc.
Epocrates is a leading provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry. Epocrates' active user network currently has more than 1.3 million healthcare professionals, including more than 45 percent of U.S. physicians. Most commonly used on mobile devices at the point of care, the company's clinical products and services help healthcare professionals make more informed prescribing decisions, enhance patient safety and improve practice productivity. For more information about Epocrates, please visit www.epocrates.com/company.
Epocrates is a trademark of Epocrates, Inc., registered in the U.S. and other countries.